Korsana Biosciences, Inc.
Common Stock · NASDAQ
Live TMS charts are coming soon.
Paper trading. Simulated, no real money.
No public theses on KRSA yet. When TMS traders open paper trades on it and make their thesis public, the long and short split, average conviction and hit rate show here.
Key stats load once market data is connected.
Korsana Biosciences filed an 8-K reporting that matters were put to a vote of its security holders. The headline and teaser give no vote results or specific proposals, so the outcome is not known from this item.
No SEC financials for KRSA yet. Companies that file 10-K and 10-Q reports show revenue, earnings, cash flow and the balance sheet here.
Source: SEC filings (10-K, 10-Q).
Paper trading only. Nothing here is financial advice.